The Odoromics™ Company
At Yesse Technologies, we are building a technology platform that harnesses the biology of the real nose and merges it with cutting-edge nanotechnology to ultimately decode the last mystery of the senses.
“With Yesse, we are on our way to replace the no in nose with a convinced yes.”
─Dr. Charlotte D’Hulst, CEO
Mission
We are on a mission to demystify the enigmatic sense of smell and to unveil a whole new world of data, Odoromics™.
We believe that our ground-breaking science can unleash the power of the nose to disrupt Flavor & Fragrance R&D pipelines and maybe one day put the nose in diagnose.
Values
We are proud to be rooted in basic science and are employing what nature has fine-tuned for us ─through millions of years of evolution─ to measure smells with the precision of the human nose. Therefore, we are building an interdisciplinary team that shares our core values of integrity, thinking out-of-the box and pushing the boundaries of the unknown.
Ecosystem
Yesse Technologies is headquartered at the Alexandria Center for Life Sciences, right at the heart of New York City’s vibrant and rapidly-growing biotech ecosystem, and has a subsidiary in Leuven, Belgium near its chip development partner imec.
The
ORion21™
Platform
The ORion21™ platform is the product of more than 30 years of fundamental research on the molecular biology of the sense of smell and is named after the constellation Orion (The Hunter), an acknowledgement to Hunter College (CUNY) where the technology was invented.
The science behind the technology has been extensively validated by Yesse’s co-founders, Drs. Paul Feinstein and Charlotte D’Hulst and has been published in the peer-reviewed journal Cell Reports in 2016.
“We employ what Biology engineered for us throughout evolution.”
─Prof. Paul Feinstein, CSO
We bring together a multidisciplinary team of dedicated scientists, engineers and entrepreneurs fueled by smart VCs and experienced advisors.
Team
“The people who are crazy enough to think they can change the world are the ones who do.“
─Steve Jobs
Leadership
Our people
Board of Directors
Investors
We are funded by smart money and our investors are considered an essential part of our team.
Turning Nanotechnology into Business
Building the Future of Life-Changing Innovation™
New York, State of Opportunity
“If you can’t invent the future, the next best thing… is to fund it.”
─John Doerr
Partners
To integrate the ORion21™ biology with state-of-the-art nanochip technology, we have partnered with R&D powerhouse imec (Belgium), the world-leading innovation hub in nanoelectronics and digital technologies.
History
Yesse Technologies reaches an important milestone in its Parkinson’s program and presents second version of its Nose-On-Chip prototype. (Press release)
Yesse Technologies awarded with an Innovative Postdoctoral Entrepreneurial Research Fellowship (I-PERF) from the NSF.
National Science Foundation awards $750,000 Phase II SBIR grant (Abstract & Press release)
MouSensor becomes Yesse Technologies, Inc., The Odoromics Company (Read more)
$3.3M Seed round closed led by imec.xpand & Alexandria Venture Investments (Read more)
Company establishes a Belgian subsidiary
Flanders Innovation & Entrepreneurship awards $1.2M grant
Michael J. Fox Foundation for Parkinsons’s Research awards $340,000 in follow-up funding (Read more)
National Science Foundation awards $225,000 Phase I SBIR grant (Read more)
CEO, Dr. Charlotte D’Hulst, wins Outstanding Pitch Award at NewYork Bio’s Annual Meeting
Michael J. Fox Foundation for Parkinson’s Research awards $100,000 pilot grant (Read more)
Core technology published in Cell Reports (Read more)
MouSensor (now Yesse Technologies) founded as a Delaware State Company
News
- Yesse Technologies Reaches an Important Milestone In Its Parkinson's Program And Presents Second Version Of Its Nose-On-Chip Prototype (September 2020)
- EIT Health: Yesse Technologies Video (November 2019)
- “Putting a Yes in No-se” published in imec Magazine (April 2019)
- CEO Charlotte D'Hulst talks to Project W and WEB (April 2019)
- “4 Million for a Biological Nose on a Chip” published in Belgian newspaper “De Tijd” (September 2018)
- CEO Charlotte D’Hulst nominated as one of the top 50 Flemish innovators for the future by Belgian newspaper “De Tijd” (September 2018)
“All possibilities are on the other side of Yes. You have to have a Yes mindset to get to Greatness.”
─John C. Maxwell